Challenges in vaccination of neonates, infants and young children

Vaccine

Volumn 32, Issue 31, 2014, Pages 3886-3894

  Pichichero, Michael E ^a  

^a ROCHESTER GENERAL HOSPITAL   (United States)

Author keywords

Antigen presenting cells; B cells; B cell receptor; CD4 T cells; Children; Cytokines; Dendritic cells; Haemophilus influenzae; Immunologic memory; Infants; MHC II; Neonate; Pediatric vaccines; Streptococcus pneumoniae; T cells; T cell receptor; Toll like receptor; Vaccination

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; NEUTRALIZING ANTIBODY; VACCINE; IMMUNOGLOBULIN G;

ADAPTIVE IMMUNITY; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL TYPE; CHILDHOOD; CYTOKINE RESPONSE; GENE EXPRESSION; HEMAGGLUTINATION INHIBITION; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOPATHOLOGY; INFANT; INFECTION PREVENTION; INNATE IMMUNITY; MEDICATION COMPLIANCE; MEMORY CELL; NEWBORN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SYSTEMS BIOLOGY; VACCINATION; ANTIBODY PRODUCTION; B LYMPHOCYTE; IMMUNE SYSTEM; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; PRESCHOOL CHILD;

ANTIBODY FORMATION; ANTIGEN-PRESENTING CELLS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CHILD, PRESCHOOL; HUMANS; IMMUNE SYSTEM; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; INFANT; INFANT, NEWBORN; VACCINATION;

EID: 84901986156     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.05.008     Document Type: Review

References (102)

1. Casey J.R., Pichichero M.E. Acellular pertussis vaccine safety and efficacy in children, adolescents and adults. Drugs 2005, 65:1367-1389.
2. Fay K.E., Lai J., Bocchini J.A. Update on childhood and adolescent immunizations: selected review of US recommendations and literature: part 1. Curr Opin Pediatr 2011, 23:460-469.
3. PrabhuDas M., Adkins B., Gans H., King C., Levy O., Ramilo O., et al. Challenges in infant immunity: implications for responses to infection and vaccines. NatImmunol 2011, 12:189-194.
4. Rainey J.J., Watkins M., Ryman T.K., Sandhu P., Bo A., Banerjee K. Reasons related to non-vaccination and under-vaccination of children in low and middle income countries: findings from a systematic review of the published literature, 1999-2009. Vaccine 2011, 29:8215-8221.
5. MacNeil A., Dietz V., Cherian T. Vaccine preventable diseases: time to re-examine global surveillance data?. Vaccine 2014, 32:2315-2320.
6. WHO. World Health Organization Global vaccine action plan 2011-2020. Geneva:World Health Organization2013.
7. Barrios C., Brawand P., Berney M., Brandt C., Lambert P.H., Siegrist C.A. Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2-biased pattern which persists after adult boosting. Eur J Immunol 1996, 26:1489-1496.
8. Delespesse G., Yang L.P., Ohshima Y., Demeure C., Shu U., Byun D.G., et al. Maturation of human neonatal CD4+ and CD8+ T lymphocytes into Th1/Th2 effectors. Vaccine 1998, 16:1415-1419.
9. Gans H., DeHovitz R., Forghani B., Beeler J., Maldonado Y., Arvin A.M. Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life. Vaccine 2003, 21:3398-3405.
10. Jonsdottir I. Maturation of mucosal immune responses and influence of maternal antibodies. J Comp Pathol 2007, 137(Suppl 1):S6-S20.
11. Li L., Lee H.H., Bell J.J., Gregg R.K., Ellis J.S., Gessner A., et al. IL-4 utilizes an alternative receptor to drive apoptosis of Th1 cells and skews neonatal immunity toward Th2. Immunity 2004, 20:429-440.
12. Petty R.E., Hunt D.W. Neonatal dendritic cells. Vaccine 1998, 16:1378-1382.
13. Philbin V.J., Levy O. Developmental biology of the innate immune response: implications for neonatal and infant vaccine development. Pediatr Res 2009, 65:98R-105R.
14. Prescott S.L., Taylor A., King B., Dunstan J., Upham J.W., Thornton C.A., et al. Neonatal interleukin-12 capacity is associated with variations in allergen-specific immune responses in the neonatal and postnatal periods. Clin Exp Allergy 2003, 33:566-572.
15. Siegrist C.A. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine 2003, 21:3406-3412.
16. Siegrist C.A., Aspinall R. B-cell responses to vaccination at the extremes of age. Nat Rev Immunol 2009, 9:185-194.
17. Upham J.W., Rate A., Rowe J., Kusel M., Sly P.D., Holt P.G. Dendritic cell immaturity during infancy restricts the capacity to express vaccine-specific T-cell memory. Infect Immun 2006, 74:1106-1112.
18. White O.J., Rowe J., Richmond P., Marshall H., McIntyre P., Wood N., et al. Th2-polarisation of cellular immune memory to neonatal pertussis vaccination. Vaccine 2010, 28:2648-2652.
19. Wilson C.B., Kollmann T.R. Induction of antigen-specific immunity in human neonates and infants. Nestle Nutr Workshop Ser Pediatr Program 2008, 61:183-195.
20. Zepp F., Knuf M., Habermehl P., Schmitt J.H., Rebsch C., Schmidtke P., et al. Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine. Infect Immun 1996, 64:4078-4084.
21. Pichichero M.E., Casey J.R., Almudevar A. Nonprotective responses to pediatric vaccines occur in children who are otitis prone. Pediatr Infect Dis J 2013, 32:1163-1168.
22. Sharma S.K., Pichichero M.E. Deficiencies in the CD4+T-Helper cell arm of the immune system of neonates and young children. Pediatr Allergy Immunol Pulmonol 2013, 26:4-10.
23. Sharma S.K., Casey J.R., Pichichero M.E. Reduced memory CD4+ T-cell generation in the circulation of young children may contribute to the otitis-prone condition. J Infect Dis 2011, 204:645-653.
24. Sharma S.K., Casey J.R., Pichichero M.E. Reduced serum IgG responses to pneumococcal antigens in otitis-prone children may be due to poor memory B-cell generation. J Infect Dis 2012, 205:1225-1229.
25. Sharma S.K., Pichichero M.E. Functional deficits of pertussis-specific CD4+ T cells in infants compared to adults following DTaP vaccination. Clin Exp Immunol 2012, 169:281-291.
26. Sharma S.K., Pichichero M.E. Cellular immune response in young children accounts for recurrent acute otitis media. Curr. Allergy and Asthma Rep. 2013, 13:495-500.
27. Kaur R., Casey J.R., Pichichero M.E. Serum antibody response to five Streptococcus pneumoniae proteins during acute otitis media in otitis-prone and non-otitis-prone children. Pediatr Infect Dis J 2011, 30:645-650.
28. Kaur R., Casey J.R., Pichichero M.E. Serum antibody response to three non-typeable Haemophilus influenzae outer membrane proteins during acute otitis media and nasopharyngeal colonization in otitis prone and non-otitis prone children. Vaccine 2011, 29:1023-1028.
29. Khan M.N., Kaur R., Pichichero M.E. Bactericidal antibody response against P6, protein D, and OMP26 of nontypeable Haemophilus influenzae after acute otitis media in otitis-prone children. FEMS Immunol Med Microbiol 2012, 65:439-447.
30. Verhoeven D., Nesselbush M., Pichichero M.E. Lower nasopharyngeal epithelial cell repair and diminished innate inflammation responses contribute to the onset of acute otitis media in otitis-prone children. Med Microbiol Immunol 2013, 202:295-302.
31. Pichichero M.E., Casey J.R., Almudevar A. Reducing the frequency of acute otitis media by individualized care. Pediatr Infect Dis J 2013, 32:473-478.
32. Sharma S.K., Roumanes D., Almudevar A., Mosmann T.R., Pichichero M.E. CD4+ T-cell responses among adults and young children in response to Streptococcus pneumoniae and Haemophilus influenzae vaccine candidate protein antigens. Vaccine 2013, 31(30):3090-3097.
33. Velilla P.A., Rugeles M.T., Chougnet C.A. Defective antigen-presenting cell function in human neonates. Clin Immunol 2006, 121:251-259.
34. Pichichero M.E. Booster vaccinations: can immunologic memory outpace disease pathogenesis. Pediatrics 2009, 124:1633-1641.
35. Pichichero M.E. Protein carriers of conjugate vaccines: characteristics, development and clinical trials. Hum Vaccin Immunother 2013, 9:2505-2523.
36. Kaufmann S.H., Juliana McElrath M., Lewis D.J., Del Giudice G. Challenges and responses in human vaccine development. Curr Opin Immunol 2014, 28c:18-26.
37. Koff W.C., Burton D.R., Johnson P.R., Walker B.D., King C.R., Nabel G.J., et al. Accelerating next-generation vaccine development for global disease prevention. Science 2013, 340:1232910.
38. Plotkin S.A. Complex correlates of protection after vaccination. Clin Infect Dis 2013, 56:1458-1465.
39. Bonhoeffer J., Siegrist C.A., Heath P.T. Immunisation of premature infants. Arch Dis Child 2006, 91:929-935.
40. Pichichero M.E., Casey J.R., Almudevar A. Non-protective responses to pediatric vaccines occur in children who are otitis prone. Pediatr Infect Dis 2013, 32(11):1163-1168.
41. Schallert N., Pihlgren M., Kovarik J., Roduit C., Tougne C., Bozzotti P., et al. Generation of adult-like antibody avidity profiles after early-life immunization with protein vaccines. Eur J Immunol 2002, 32:752-760.
42. Adkins B., Leclerc C., Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat Rev Immunol 2004, 4:553-564.
43. Kaur K., Chowdhury S., Greenspan N.S., Schreiber J.R. Decreased expression of tumor necrosis factor family receptors involved in humoral immune responses in preterm neonates. Blood 2007, 110:2948-2954.
44. Viemann D., Schlenke P., Hammers H.J., Kirchner H., Kruse A. Differential expression of the B cell-restricted molecule CD22 on neonatal B lymphocytes depending upon antigen stimulation. Eur J Immunol 2000, 30:550-559.
45. Somani A.K., Yuen K., Xu F., Zhang J., Branch D.R., Siminovitch K.A. The SH2 domain containing tyrosine phosphatase-1 down-regulates activation of Lyn and Lyn-induced tyrosine phosphorylation of the CD19 receptor in B cells. J Biol Chem 2001, 276:1938-1944.
46. Avalos A.M., Ploegh H.L. Early BCR events and antigen capture, processing, and loading on MHC class II on B cells. Front Immunol 2014, 5:92.
47. Yuseff M.I., Pierobon P., Reversat A., Lennon-Dumenil A.M., How B cells capture, process and present antigens: a crucial role for cell polarity. Nat Rev Immunol 2013, 13:475-486.
48. van Kooten C., Banchereau J. CD40-CD40 ligand. J Leukoc Biol 2000, 67:2-17.
49. Han P., McDonald T., Hodge G. Potential immaturity of the T-cell and antigen-presenting cell interaction in cord blood with particular emphasis on the CD40-CD40 ligand costimulatory pathway. Immunology 2004, 113:26-34.
50. Kaminski B.A., Kadereit S., Miller R.E., Leahy P., Stein K.R., Topa D.A., et al. Reduced expression of NFAT-associated genes in UCB versus adult CD4+ T lymphocytes during primary stimulation. Blood 2003, 102:4608-4617.
51. Mastelic B., Kamath A.T., Fontannaz P., Tougne C., Rochat A.F., Belnoue E., et al. Environmental and T cell-intrinsic factors limit the expansion of neonatal follicular T helper cells but may be circumvented by specific adjuvants. J Immunol 2012, 189:5764-5772.
52. Holt P.G. Functionally mature virus-specific CD8(+) T memory cells in congenitally infected newborns: proof of principle for neonatal vaccination. J Clin Invest 2003, 111:1645-1647.
53. He X.S., Holmes T.H., Mahmood K., Kemble G.W., Dekker C.L., Arvin A.M., et al. Phenotypic changes in influenza-specific CD8+ T cells after immunization of children and adults with influenza vaccines. J Infect Dis 2008, 197:803-811.
54. McCarron M.J., Reen D.J. Neonatal CD8+ T-cell differentiation is dependent on interleukin-12. Hum Immunol 2010, 71:1172-1179.
55. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 Cells. Annu Rev Immunol 2009, 27:485-517.
56. Kaplan M.H. Th9 cells: differentiation and disease. Immunol Rev 2013, 252:104-115.
57. Basu R., O'Quinn D.B., Silberger D.J., Schoeb T.R., Fouser L., Ouyang W., et al. Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity 2012, 37:1061-1075.
58. Ramiscal R.R., Vinuesa C.G. T-cell subsets in the germinal center. Immunol Rev 2013, 252:146-155.
59. Kara E.E., Comerford I., Fenix K.A., Bastow C.R., Gregor C.E., McKenzie D.R., et al. Tailored immune responses: novel effector helper T cell subsets in protective immunity. PLoS Pathog 2014, 10:e1003905.
60. Cuenca A.G., Wynn J.L., Moldawer L.L., Levy O. Role of innate immunity in neonatal infection. Am J Perinatol 2013, 30:105-112.
61. Belderbos M.E., van Bleek G.M., Levy O., Blanken M.O., Houben M.L., Schuijff L., et al. Skewed pattern of Toll-like receptor 4-mediated cytokine production in human neonatal blood: low LPS-induced IL-12p70 and high IL-10 persist throughout the first month of life. Clin Immunol 2009, 133:228-237.
62. Marodi L. Innate cellular immune responses in newborns. Clin Immunol 2006, 118:137-144.
63. Vosters O., Lombard C., André F., Sana G., Sokal E.M., Smets F. The interferon-alpha and interleukin-10 responses in neonates differ from adults, and their production remains partial throughout the first 18 months of life. Clin Exp Immunol 2010, 162:494-499.
64. Klein N.P., Gans H.A., Sung P., Yasukawa L.L., Johnson J., Sarafanov A., et al. Preterm infants' T cell responses to inactivated poliovirus vaccine. J Infect Dis 2010, 201:214-222.
65. Klein Klouwenberg P., Bont L. Neonatal and infantile immune responses to encapsulated bacteria and conjugate vaccines. Clin Dev Immunol 2008, 2008:628693.
66. Sharma S.K., Roumanes D., Almudevar A., Mosmann T.R., Pichichero M.E. CD4(+) T-cell responses among adults and young children in response to Streptococcus pneumoniae and Haemophilus influenzae vaccine candidate protein antigens. Vaccine 2013, 31:3090-3097.
67. Bryant V.L., Ma C.S., Avery D.T., Li Y., Good K.L., Corcoran L.M., et al. Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells. J Immunol 2007, 179:8180-8190.
68. Zaghouani H., Hoeman C.M., Adkins B. Neonatal immunity: faulty T-helpers and the shortcomings of dendritic cells. Trends Immunol 2009, 30:585-591.
69. Surh C.D., Boyman O., Purton J.F., Sprent J. Homeostasis of memory T cells. Immunol Rev 2006, 211:154-163.
70. Upham J.W., Lee P.T., Holt B.J., Heaton T., Prescott S.L., Sharp M.J., et al. Development of interleukin-12-producing capacity throughout childhood. Infect Immun 2002, 70:6583-6588.
71. Palin A.C., Ramachandran V., Acharya S., Lewis D.B. Human neonatal naive CD4+ T cells have enhanced activation-dependent signaling regulated by the microRNA miR-181a. J Immunol 2013, 190:2682-2691.
72. Miscia S., Di Baldassarre A., Sabatino G., Bonvini E., Rana R.A., Vitale M., et al. Inefficient phospholipase C activation and reduced Lck expression characterize the signaling defect of umbilical cord T lymphocytes. J Immunol 1999, 163:2416-2424.
73. Schneider O.D., Weiss A.A., Miller W.E. Pertussis toxin utilizes proximal components of the T-cell receptor complex to initiate signal transduction events in T cells. Infect Immun 2007, 75:4040-4049.
74. Canto E., Rodriguez-Sanchez J.L., Vidal S. Distinctive response of naive lymphocytes from cord blood to primary activation via TCR. J Leukoc Biol 2003, 74:998-1007.
75. O'Neill R.M., Hassan J., Reen D.J. IL-7-regulated homeostatic maintenance of recent thymic emigrants in association with caspase-mediated cell proliferation and apoptotic cell death. J Immunol 2003, 170:4524-4531.
76. Smeets R.L., Fleuren W.W., He X., Vink P.M., Wijnands F., Gorecka M., et al. Molecular pathway profiling of T lymphocyte signal transduction pathways; Th1 and Th2 genomic fingerprints are defined by TCR and CD28-mediated signaling. BMC Immunol 2012, 13:12.
77. de Roock S., Stoppelenburg A.J., Scholman R., Hoeks S.B., Meerding J., Prakken B.J., et al. Defective TH17 development in human neonatal T cells involves reduced RORC2 mRNA content. J Allergy Clin Immunol 2013, 132:754-756. e3.
78. Strunk T., Currie A., Richmond P., Simmer K., Burgner D. Innate immunity in human newborn infants: prematurity means more than immaturity. J Matern Fetal Neonatal Med 2011, 24:25-31.
79. Willems F., Vollstedt S., Suter M. Phenotype and function of neonatal DC. Eur J Immunol 2009, 39:26-35.
80. Kollmann T.R., Crabtree J., Rein-Weston A., Blimkie D., Thommai F., Wang X.Y., et al. Neonatal innate TLR-mediated responses are distinct from those of adults. J Immunol 2009, 183:7150-7160.
81. Ma C.S., Suryani S., Avery D.T., Chan A., Nanan R., Santner-Nanan B., et al. Early commitment of naive human CD4(+) T cells to the T follicular helper (T(FH)) cell lineage is induced by IL-12. Immunol Cell Biol 2009, 87:590-600.
82. von Andrian U.H., Mempel T.R. Homing and cellular traffic in lymph nodes. Nat Rev Immunol 2003, 3:867-878.
83. Huang G., Wang Y., Chi H. Regulation of TH17 cell differentiation by innate immune signals. Cell Mol Immunol 2012, 9:287-295.
84. Yamane H., Paul W.E. Early signaling events that underlie fate decisions of naive CD4(+) T cells toward distinct T-helper cell subsets. Immunol Rev 2013, 252:12-23.
85. Cella M., Salio M., Sakakibara Y., Langen H., Julkunen I., Lanzavecchia A. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J Exp Med 1999, 189:821-829.
86. Hertz C.J., Kiertscher S.M., Godowski P.J., Bouis D.A., Norgard M.V., Roth M.D., et al. Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2. J Immunol 2001, 166:2444-2450.
87. Kawai T., Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011, 34:637-650.
88. Kollmann T.R., Levy O., Montgomery R.R., Goriely S. Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity 2012, 37:771-783.
89. Corbett N.P., Blimkie D., Ho K.C., Cai B., Sutherland D.P., Kallos A., et al. Ontogeny of Toll-like receptor mediated cytokine responses of human blood mononuclear cells. PLoS One 2010, 5:e15041.
90. Burl S., Townend J., Njie-Jobe J., Cox M., Adetifa U.J., Touray E., et al. Age-dependent maturation of Toll-like receptor-mediated cytokine responses in Gambian infants. PLoS One 2011, 6:e18185.
91. Wynn J.L., Scumpia P.O., Winfield R.D., Delano M.J., Kelly-Scumpia K., Barker T., et al. Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists. Blood 2008, 112:1750-1758.
92. Querec T., Bennouna S., Alkan S., Laouar Y., Gorden K., Flavell R., et al. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J Exp Med 2006, 203:413-424.
93. Querec T.D., Akondy R.S., Lee E.K., Cao W., Nakaya H.I., Teuwen D., et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol 2009, 10:116-125.
94. Kasturi S.P., Skountzou I., Albrecht R.A., Koutsonanos D., Hua T., Nakaya H.I., et al. Programming the magnitude and persistence of antibody responses with innate immunity. Nature 2011, 470:543-547.
95. Kimman T.G., Banus S., Reijmerink N., Reimerink J., Stelma F.F., Koppelman G.H., et al. Association of interacting genes in the toll-like receptor signaling pathway and the antibody response to pertussis vaccination. PLoS One 2008, 3:e3665.
96. Wolfle S.J., Strebovsky J., Bartz H., Sahr A., Arnold C., Kaiser C., et al. PD-L1 expression on tolerogenic APCs is controlled by STAT-3. Eur J Immunol 2011, 41:413-424.
97. Langrish C.L., Buddle J.C., Thrasher A.J., Goldblatt D. Neonatal dendritic cells are intrinsically biased against Th-1 immune responses. Clin Exp Immunol 2002, 128:118-123.
98. De Wit D., Tonon S., Olislagers V., Goriely S., Boutriaux M., Goldman M., et al. Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood. J Autoimmun 2003, 21:277-281.
99. Li S., Rouphael N., Duraisingham S., Romero-Steiner S., Presnell S. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat Immunol 2014, 15:195-204.
100. Kennedy R.B., Oberg A.L., Ovsyannikova I.G., Haralambieva I.H., Grill D., Poland G.A. Transcriptomic profiles of high and low antibody responders to smallpox vaccine. Genes Immun 2013, 14:277-285.
101. Liu K., Chen L., Kaur R., Pichichero M. Transcriptome signature in young children with acute otitis media due to Streptococcus pneumoniae. Microbes Infect 2012, 14:600-609.
102. Liu K., Chen L., Kaur R., Pichichero M.E. Transcriptome signature in young children with acute otitis media due to non-typeable Haemophilus influenzae. Int Immunol 2013, 25:353-361.